肾小球病变伴纤维沉积。

Pavlina Dzekova-Vidimliski, Vlatko Karanfilovski, Igor G Nikolov, Irena Rambabova-Bushljetik, Vesna Ristovska, Gordana Petrushevska, Gjulsen Selim
{"title":"肾小球病变伴纤维沉积。","authors":"Pavlina Dzekova-Vidimliski,&nbsp;Vlatko Karanfilovski,&nbsp;Igor G Nikolov,&nbsp;Irena Rambabova-Bushljetik,&nbsp;Vesna Ristovska,&nbsp;Gordana Petrushevska,&nbsp;Gjulsen Selim","doi":"10.2478/prilozi-2023-0030","DOIUrl":null,"url":null,"abstract":"<p><p>The glomerulopathies associated with the deposition of extracellular fibrils in the glomeruli are subdivided into Congo red positive (amyloidosis) and Congo red negative (non-amyloidotic glomerulopathies) based on Congo red staining. The non-amyloidotic glomerulopathies are divided into immunoglobulin-derived and non-immunoglobulin-derived glomerulopathies. The immunoglobulin-derived glomerulopathies: fibrillary glomerulopathy (FGn) and immunotactoid glomerulopathy (ITG) are rare glomerulopathies. The diagnosis of fibrillary-immunotactoid glomerulopathy depends on electron microscopy, which shows the presence of microfibrils in the glomeruli. The microfibrils in FGn are randomly arranged with diameters less than 30 nm. The microfibrils in ITG are larger than 30 nm with a visible lumen (microtubules), focally arranged in parallel bundles. Patients with fibrillary-immunotactoid glomerulopathy present with proteinuria (usually in the nephrotic range), microscopic hematuria, arterial hypertension, and chronic kidney disease that progresses to kidney failure over months to years. Currently, there are no guidelines for the treatment of fibrillary-immunotactoid glomerulopathy, although immunotactoid glomerulopathy could be associated with underlying hematologic disorders with the need for clone-directed therapy.</p>","PeriodicalId":74492,"journal":{"name":"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)","volume":"44 2","pages":"99-106"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Glomerulopathies with Fibrillary Deposits.\",\"authors\":\"Pavlina Dzekova-Vidimliski,&nbsp;Vlatko Karanfilovski,&nbsp;Igor G Nikolov,&nbsp;Irena Rambabova-Bushljetik,&nbsp;Vesna Ristovska,&nbsp;Gordana Petrushevska,&nbsp;Gjulsen Selim\",\"doi\":\"10.2478/prilozi-2023-0030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The glomerulopathies associated with the deposition of extracellular fibrils in the glomeruli are subdivided into Congo red positive (amyloidosis) and Congo red negative (non-amyloidotic glomerulopathies) based on Congo red staining. The non-amyloidotic glomerulopathies are divided into immunoglobulin-derived and non-immunoglobulin-derived glomerulopathies. The immunoglobulin-derived glomerulopathies: fibrillary glomerulopathy (FGn) and immunotactoid glomerulopathy (ITG) are rare glomerulopathies. The diagnosis of fibrillary-immunotactoid glomerulopathy depends on electron microscopy, which shows the presence of microfibrils in the glomeruli. The microfibrils in FGn are randomly arranged with diameters less than 30 nm. The microfibrils in ITG are larger than 30 nm with a visible lumen (microtubules), focally arranged in parallel bundles. Patients with fibrillary-immunotactoid glomerulopathy present with proteinuria (usually in the nephrotic range), microscopic hematuria, arterial hypertension, and chronic kidney disease that progresses to kidney failure over months to years. Currently, there are no guidelines for the treatment of fibrillary-immunotactoid glomerulopathy, although immunotactoid glomerulopathy could be associated with underlying hematologic disorders with the need for clone-directed therapy.</p>\",\"PeriodicalId\":74492,\"journal\":{\"name\":\"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)\",\"volume\":\"44 2\",\"pages\":\"99-106\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2478/prilozi-2023-0030\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/prilozi-2023-0030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

根据刚果红染色,与肾小球内细胞外原纤维沉积相关的肾小球病变可细分为刚果红阳性(淀粉样变性)和刚果红阴性(非淀粉样变性肾小球病变)。非淀粉样变性肾小球病分为免疫球蛋白源性肾小球病和非免疫球蛋白源性肾小球病。免疫球蛋白源性肾小球病:纤原性肾小球病(FGn)和免疫球蛋白样肾小球病(ITG)是罕见的肾小球病。纤维性免疫球蛋白样肾小球病变的诊断依赖于电子显微镜,它显示肾小球中存在微原纤维。FGn中的微原纤维是随机排列的,直径小于30nm。ITG中的微原纤维大于30 nm,可见管腔(微管),局部平行排列。纤维性免疫球蛋白样肾小球病变患者表现为蛋白尿(通常在肾病范围内)、显微镜下血尿、动脉性高血压和慢性肾脏疾病,并在数月至数年内发展为肾衰竭。目前,尽管免疫球蛋白样肾小球病变可能与潜在的血液系统疾病相关,需要克隆定向治疗,但尚无纤维性免疫球蛋白样肾小球病变的治疗指南。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Glomerulopathies with Fibrillary Deposits.

The glomerulopathies associated with the deposition of extracellular fibrils in the glomeruli are subdivided into Congo red positive (amyloidosis) and Congo red negative (non-amyloidotic glomerulopathies) based on Congo red staining. The non-amyloidotic glomerulopathies are divided into immunoglobulin-derived and non-immunoglobulin-derived glomerulopathies. The immunoglobulin-derived glomerulopathies: fibrillary glomerulopathy (FGn) and immunotactoid glomerulopathy (ITG) are rare glomerulopathies. The diagnosis of fibrillary-immunotactoid glomerulopathy depends on electron microscopy, which shows the presence of microfibrils in the glomeruli. The microfibrils in FGn are randomly arranged with diameters less than 30 nm. The microfibrils in ITG are larger than 30 nm with a visible lumen (microtubules), focally arranged in parallel bundles. Patients with fibrillary-immunotactoid glomerulopathy present with proteinuria (usually in the nephrotic range), microscopic hematuria, arterial hypertension, and chronic kidney disease that progresses to kidney failure over months to years. Currently, there are no guidelines for the treatment of fibrillary-immunotactoid glomerulopathy, although immunotactoid glomerulopathy could be associated with underlying hematologic disorders with the need for clone-directed therapy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信